Digital PCR Market in COVID-19: Implications and Opportunities for Growth in all regions

The value of the digital PCR market in 2017 was $310 million, and is expected to reach $162 million, an average annual growth of 18.0% from 2018 to 2025 by 2025. North America made the biggest contribution to the digital PCR market in 2017. However, the Asia Pacific region is expected to show the highest growth during the forecast period.

Digital PCR is a simple and reproducible method that does not rely on calibration curves for quantifying sample targets. Accurate and highly sensitive quantification of nucleic acids is possible. Used for absolute quantification and analysis of fractional sequences. This type of PCR enhances the sensitivity of real-time PCR and detects rare events such as single nucleotide mutations in wild-type sequence populations. Using digital PCR, the sample is split such that individual nucleic acid molecules in the sample are localized and concentrated within multiple individual regions. After PCR amplification, nucleic acids can be quantified by counting the region containing the PCR final product and positive reaction.

Click here to access the free sample report: https://www.alliedmarketresearch.com/request-sample/654

The main factors driving the growth of the digital PCR market are the spread of epidemics, increased awareness and acceptance of personalized medicines, and technological advances in the field of digital PCR.

However, high cost digital PCR devices and redemption issues limit market growth. However, the increase in funding for R&D activities is expected to provide many opportunities for market growth during the forecast period.
Based on the technology, the market branches into droplet digital PCR (ddPCR) and BEAMing digital PCR. The ddPCR segment was a major revenue contributor in 2017 and is expected to continue this trend during the forecast period, and the ddPCR technology accurately measures DNA molecules through each drop. In addition, bulk sample partitioning is a key component of droplet digital PCR technology, increasing demand.

By type, the market is categorized into digital PCR systems, consumables and reagents, software and services. The software and services sector is expected to experience rapid growth over the forecast period as software improves digital PCR data management efficiency and promotes market growth as demand for these products increases.

North America was the main revenue contributor to the global digital polymerase chain reaction market in 2017, and is expected to maintain its dominant position throughout the forecast period. This is due to the well-developed healthcare industry, the presence of leading molecular diagnostic manufacturers in the region, and an increased number of patients using personalized medicines. However, the Asia-Pacific region is expected to grow to a CAGR of up to 19.1% during the study period, as the number of patients suffering from chronic diseases increases and the medical facilities in the area improve, providing a favorable opportunity for molecular diagnostic players. .

Purchase Inquiries: https://www.alliedmarketresearch.com/purchase-enquiry/654

Key results from the digital PCR market:
• Based on the application, the forensic sector is expected to grow at the highest rate during the analysis period.
• North America dominated the global digital PCR market in 2017 and is expected to continue to dominate.
• During the forecast period, China is expected to grow at the highest rate in the Asia Pacific region.
• Consumables and reagents made the biggest contribution in 2017, depending on the product type.
• Based on technology, the ddPCR segment has the highest revenue and is expected to continue to dominate.

Bio-Rad Laboratories, Inc. is a major player in the global digital PCR market. (RainDance Technologies, Inc.), Expedeon AG, Fluidigm Corporation, JN Medsys, Merck KGaA, Qiagen NV (Formulatrix, Inc.), Stilla Technologies, Sysmex Corporation (Sysmex Inostics GmbH) and Thermo Fisher Scientific, Inc.

Get detailed (COVID-19 impact) analysis:
https://www.alliedmarketresearch.com/digital-polymerase-chain-reaction-market

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web:https://www.alliedmarketresearch.com
Follow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.